Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still's disease/systemic lupus erythematosus: insights from nine cases. [PDF]
Front ImmunolChen J +9 more
europepmc +1 more source
Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis. [PDF]
Clin Transl SciBrossard P.
europepmc +1 more source
Brain microhemorrhages in adult-onset Still's disease: A case report. [PDF]
Medicine (Baltimore)Kim JY, Choi HJ, Kim SH.
europepmc +1 more source
[Adult-onset Still's disease].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993 openaire +1 more source
Beyond Hyperferritinemia: Evaluating Ferritin as a Predictor of Advanced Therapy in Adult-Onset Still's Disease. [PDF]
Diagnostics (Basel)Kang JH.
europepmc +1 more source
Evaluation of clinical biomarkers for differential diagnosis of intravascular lymphoma and Still's disease. [PDF]
Sci RepShima T +5 more
europepmc +1 more source
Macrophage activation syndrome complicating adult-onset Still's disease: the case for standardized guidelines. [PDF]
Proc (Bayl Univ Med Cent)Vaseer S.
europepmc +1 more source
Related searches:
Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology and pathogenesis. AOSD is a rare condition, usually presenting with high fever accompanied by systemic manifestations. The disease is a heterogeneous pathological entity with a range of etiologies, manifestations and prognosis.
János, Kádár, Edina, Petrovicz
openaire +2 more sources
Three patients with adult onset of Still's disease are presented. Common early findings were: septic fever, polyarthralgia, leukocytosis, neutrophilia and elevated sedimentation rate. All of them had abnormal liver function tests which returned to normal values following corticosteroid therapy.
N, Arber +4 more
openaire +2 more sources